Lactulose Ratiopharm (Lactulose)

Lactulose is a synthetic sugar that reaches the colon unchanged, where gut bacteria ferment it into short‑chain fatty acids. This process raises the osmotic pressure in the intestinal lumen, drawing water into the colon, softening stool, and acidifying the environment, which traps ammonia as ammonium and lowers its systemic levels.

The dose of Lactulose Ratiopharm is individualized by the prescribing healthcare professional based on the patient’s condition, age, and response. The prescriber determines the appropriate amount and frequency to achieve the desired therapeutic effect while minimizing side effects.

Safety data for Lactulose in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider after evaluating the clinical situation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose is an osmotic laxative, differing from stimulant laxatives that increase intestinal motility. Compared with polyethylene glycol, Lactulose also lowers ammonia levels, making it useful in hepatic encephalopathy. Choice of therapy depends on the underlying condition, patient tolerance and physician preference.

Lactulose Ratiopharm should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Lactulose Ratiopharm is taken orally, usually as a liquid solution. It can be measured with a calibrated dosing device and mixed with a small amount of water or juice if desired. The exact administration schedule is set by the prescribing clinician.

Serious risks include severe electrolyte imbalance, marked dehydration, and rare allergic reactions such as rash or swelling. Patients should be monitored for signs of these conditions, especially when high doses are used or when combined with other medications that affect fluid and electrolyte balance.

Lactulose should be avoided in individuals with known hypersensitivity to lactulose or any component of the formulation. Caution is advised for patients with severe renal impairment, uncontrolled diabetes, or those taking other strong laxatives without medical supervision.